New insights in the immunologic basis of psoriasis.
Psoriasis vulgaris is a multifactorial heritable disease characterized by severe inflammation resulting in poorly differentiated, hyperproliferative keratinocytes. Recent advances in genetic analyses have implicated components regulating the interleukin (IL)-23 and nuclear factor-kappaB pathways as risk factors for psoriasis. These inflammatory pathways exhibit increased activity in skin lesions, and promote secretion of various cytokines, such as IL-17 and IL-22. Unrestrained, the activated inflammatory cytokine network in psoriasis may trigger a vicious cycle of inflammation and cellular proliferation that ultimately results in lesion formation. These advances in genetic analyses, together with the progress made in targeted biological therapy, pave the path to tailor treatment on the basis of an individual's genetic and immunologic profile.
Nograles
Kristine E
KE
Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY 10065, USA.
Davidovici
Batya
B
Krueger
James G
JG
D015496:CD4-Positive T-Lymphocytes / Q000502:physiology; D006801:Humans; D053759:Interleukin-23 / Q000502:physiology; D007378:Interleukins / Q000502:physiology; D008213:Lymphocyte Activation / Q000502:physiology; D011565:Psoriasis / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D000097043:Interleukin-22
D053759:Interleukin-23; D007378:Interleukins; D000097043:Interleukin-22